| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Jubilant Life Sciences Limited (NSE: JUBILANT)
JUBILANT Technical Analysis
1
| As on N/A JUBILANT SHARE Price closed @ N/A and we RECOMMEND N/A for LONG-TERM with Stoploss of N/A & N/A for SHORT-TERM with Stoploss of N/A we also expect STOCK to react on Following IMPORTANT LEVELS. |
JUBILANTSHARE Price
| Open | N/A | Change | Price | % |
| High | N/A | 1 Day | N/A | N/A |
| Low | N/A | 1 Week | N/A | N/A |
| Close | N/A | 1 Month | N/A | N/A |
| Volume | N/A | 1 Year | N/A | N/A |
| 52 Week High N/A | 52 Week Low N/A | ||||
NSE INDIA Most Active Stocks
| IDEA | 7.93 | -1.00% |
| GTLINFRA | 1.60 | 6.67% |
| RPOWER | 44.37 | 1.93% |
| SUZLON | 60.11 | 0.20% |
| YESBANK | 18.43 | 0.05% |
| IDFCFIRSTB | 67.65 | -1.17% |
| GATECH | 0.76 | 8.57% |
| MMTC | 61.85 | 10.78% |
| MOREPENLAB | 62.22 | 14.12% |
| JYOTISTRUC | 21.69 | 2.17% |
NSE INDIA Top Gainers Stocks
| ELDEHSG | 880.60 | 20.00% |
| MODIRUBBER | 151.08 | 20.00% |
| REPRO | 556.95 | 19.99% |
| GSS | 44.97 | 19.98% |
| GSS | 44.97 | 19.98% |
| GSS | 44.97 | 19.98% |
| GSS | 44.97 | 19.98% |
| MUFIN | 79.80 | 19.18% |
| INDBANK | 37.70 | 15.01% |
| MOREPENLAB | 62.22 | 14.12% |
NSE INDIA Top Losers Stocks
| JUBILANT Daily Charts |
JUBILANT Intraday Charts |
Whats New @ Bazaartrend |
JUBILANT Free Analysis |
|
|
JUBILANT Important Levels Intraday
| RESISTANCE | |
| RESISTANCE | |
| RESISTANCE | |
| RESISTANCE | |
| RESISTANCE | |
| RESISTANCE | |
| RESISTANCE | |
| RESISTANCE |
JUBILANT Target April 2025
| 4th UP Target | |
| 3rd UP Target | |
| 2nd UP Target | |
| 1st UP Target | |
| 1st DOWN Target | |
| 2nd DOWN Target | |
| 3rd DOWN Target | |
| 4th DOWN Target |
JUBILANT Weekly Target
| 4th UP Target | |
| 3rd UP Target | |
| 2nd UP Target | |
| 1st UP Target | |
| 1st DOWN Target | |
| 2nd DOWN Target | |
| 3rd DOWN Target | |
| 4th DOWN Target |
JUBILANT Target2025
| 4th UP Target | |
| 3rd UP Target | |
| 2nd UP Target | |
| 1st UP Target | |
| 1st DOWN Target | |
| 2nd DOWN Target | |
| 3rd DOWN Target | |
| 4th DOWN Target |
Jubilant Life Sciences Limited ( NSE INDIA Symbol : JUBILANT )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
JUBILANT Synopsis Technicals View
| 50 Day EMA |
Close is Below EMA 50 (Short Term) |
Bearish | |
| 100 Day EMA | Close is Below EMA 100 (Mid Term) | Bearish | |
| 200 Day EMA | Close is Below EMA 200 (Long Term) | Bearish | |
| MACD (12 26 9) | MACD Line is Less Then SIGNAL Line | Bearish | |
| RSI (14) | RSI is Below 30 | Over Sold | |
| MFI (14) | MFI is Below 20 | Over Sold | |
| CCI (20) | CCI is Below -100 | Over Sold | |
| WILLIAM %R (14) | William %R is Below -80 | Over Sold | |
| ADX (14) | ADX is Above 20 & +DI is Below -DI | Down Trend | |
| PSAR | Stoploss For Short Sell | 437.46 | |
| 10 Day Avg Volume | Traded -13.94 % Less then 10 Day Average Volume | ||
JUBILANT Other Details
| Segment | EQ | |
| Market Capital | 12943803392.00 | |
| Sector | Healthcare | |
| Industry | Drug Manufacturers - Major | |
| Offical website | > | |
JUBILANT Address
 |
1-A, Sector 16A Noida, 201301 India Phone: 91 12 0251 6601 Fax: 91 12 0251 6628 |
|
JUBILANT Latest News
JUBILANT Business Profile
Jubilant Life is in the Pharmaceuticals sector. Jubilant Life Sciences Limited, is an integrated Pharmaceutical & Life Sciences company. As India's largest Custom Research and Manufacturing Services (CRAMS) player and a leading Drug Discovery and Development Solutions provider out of India, it is constantly engaged in delivering value to its global customers through innovative technologies, products and services.
The Company's strategic focus is to innovate, collaborate and accelerate the process of delivering products to the market for its customers. Today, it is well recognised as a Partner of Choice’ by leading global pharmaceutical and Life Sciences companies. The Company through its presence in India, USA, Canada, Europe and China constantly serves its customers spread across 98 countries.
The current market capitalisation stands at Rs 2,216.40 crore.The company has reported a consolidated sales of Rs 1435.62 crore and a Net Loss of Rs 79.46 crore for the quarter ended Sep 2013.
The company management includes Shyam S Bhartia - Chairman & Managing Director, Hari S Bhartia - Co-Chairman & Manag. Director, Shyamsundar Bang - Executive Director, Sudha Pillai - Additional Director, Abhay Havaldar - Director, Shardul S Shroff - Director, Inder Mohan Verma - Director, Suresh Kumar - Director, S Sridhar - Director.
It is listed on the BSE with a BSE Code of 530019 and the NSE with an NSE Code of JUBILANT.
Its Registered office is at Bhartiagram, Gajraula,,Distt.Jyotiba Phoolay Nagar Jyotiba Phuley Nagar,Uttar Pradesh - 244223.Their Registrars are Ankit Assignments Ltd.
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service